CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

The U.S. Food and Drug Administration said on Monday that it is revising the labeling of all extended-release stimulants to ...

A review of the front page stories from the daily newspapers in Scotland.

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...

Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...

Woman who dropped 35 kg shares 10 so-called healthy foods she cut out to shed weight. According to her, here’s what to avoid ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...